Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Direct Selective Laser Trabeculoplasty With the Post-treatment Addition of Combination Netarsudil and Latanoprost vs Latanoprost Monotherapy

NCT07465913 is registered in ClinicalTrials.gov with Eye Centers of Southeast Texas as lead sponsor.

NCT NCT07465913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07465913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Direct Selective Laser Trabeculoplasty With the Post-treatment Addition of Combination Netarsudil and Latanoprost vs Latanoprost Monotherapy
Lead sponsor
Eye Centers of Southeast Texas
Phase
Phase 4
Overall status
Recruiting
Start date
May 14, 2026
Completion date
May 6, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma